Taizhou, China

Hongguo Lu

This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Yangtze River Pharmaceutical Group Co., Ltd., China Pharmaceutical University, Chinese Academy of Sciences. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hongguo Lu. Retrieved from https://idiyas.com/inventor/hongguo-lu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0



Average Co-Inventor Count = 4.8

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Inventor Hongguo Lu**

Introduction

Hongguo Lu is a notable inventor based in Taizhou, China, with a significant impact in the field of medicinal chemistry. He holds two patents that highlight his innovative approach to healthcare solutions, showcasing his expertise in pharmaceutical preparations and therapeutic methods.

Latest Patents

Hongguo Lu's latest patents demonstrate his focus on the development of novel medical compounds. One of his key inventions is titled **"Tetrahydro isoquinoline derivatives, preparation methods and medicinal uses thereof."** This patent describes a specific class of tetrahydro isoquinoline derivatives, their preparation methods, and medicinal uses, particularly their application as a k-opioid receptor excitant for pain relief. The intricate details of the substituents in the general formula (I) are thoroughly defined in the patent description, emphasizing the relevance of his work in pain management.

Another significant contribution is his patent on the **"Oral preparation of dyclonine hydrochloride."** This invention outlines a unique oral formulation designed for endoscopic examinations of the upper gastrointestinal tract. The formulation not only provides anesthetization and lubrication but also prevents foaming within the body cavity and reduces the risk of vomiting, thereby ensuring a clearer view during procedures. Key ingredients in this preparation include 0.2%-3% dyclonine hydrochloride, among other components, while maintaining a viscosity of 30 to 300 mpa·s and a pH range of 2.0 to 8.0.

Career Highlights

Throughout his career, Hongguo Lu has worked with reputable organizations such as the Yangtze River Pharmaceutical Group Co., Ltd. and China Pharmaceutical University. His contributions to these institutions have helped advance research and development in pharmaceutical sciences, showcasing his commitment to innovation in healthcare.

Collaborations

In addition to his individual accomplishments, Lu has collaborated with talented professionals in his field, including coworkers Tianjiang Sun and Yungen Xu. These collaborations have likely fostered an environment of shared knowledge and increased innovation, further enhancing the development of new pharmaceutical applications.

Conclusion

Hongguo Lu's work reflects his dedication to advancing medical science through innovative inventions. With a focus on creating effective pharmaceutical preparations, his patents hold promise for enhancing patient care and treatment outcomes. As the field of medicinal chemistry continues to evolve, the contributions of inventors like Hongguo Lu remain crucial in shaping the future of healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…